LC
LUNG icon

Lindbrook Capital’s Pulmonx LUNG Stock Holding History

Lindbrook Capital’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,004
Closed -$8.32K – 2857
2024
Q3 		$8.32K Buy
+1,004
New +$7.26K ﹤0.01% 1776
2024
Q2 		– Sell
-416
Closed -$3.86K – 2811
2024
Q1 		$3.86K Hold
416
– – ﹤0.01% 2016
2023
Q4 		$5.3K Buy
416
+47
+13% +$490 ﹤0.01% 1852
2023
Q3 		$3.81K Hold
369
– – ﹤0.01% 1890
2023
Q2 		$4.84K Hold
369
– – ﹤0.01% 1821
2023
Q1 		$4.13K Hold
369
– – ﹤0.01% 1929
2022
Q4 		$3.11K Buy
369
+170
+85% +$1.62K ﹤0.01% 2033
2022
Q3 		$3K Buy
199
+184
+1,227% +$3.39K ﹤0.01% 1887
2022
Q2 		$0 Sell
15
-2
-12% -$41 ﹤0.01% 2640
2022
Q1 		$0 Buy
+17
New +$439 ﹤0.01% 2558

Other funds holding LUNG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Lindbrook Capital's LUNG Position: Q4 2024 in Review

Lindbrook Capital sold out of Pulmonx (LUNG) in Q4 2024, closing a stake of 1,004 shares — an estimated $8.32K sold.

Lindbrook Capital first reported a position in LUNG in Q1 2022 and held it in 10 quarters. The position peaked at $8.32K in Q3 2024. 118 funds tracked by Wall St. Rank hold LUNG as of Q4 2024.

  • Lindbrook Capital reported no remaining Pulmonx position as of Q4 2024 after selling out during the quarter.
  • Lindbrook Capital sold 1,004 Pulmonx shares in Q4 2024, an estimated $8.32K.
  • Lindbrook Capital first reported a position in Pulmonx in Q1 2022 and held it in 10 quarters.
  • Lindbrook Capital's Pulmonx position peaked at $8.32K in Q3 2024.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q4 2024.

Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.